MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.280
-0.600 (-15.46%)
At close: Nov 2, 2026, 4:00 PM EST
3.350
+0.070 (2.13%)
After-hours: Nov 2, 2026, 5:58 PM EST

MiMedx Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
303.73418.63348.88321.48267.84242.02
Revenue Growth
-22.80%19.99%8.52%20.03%10.67%-2.50%
Gross Profit
234.75345.62288.81266.84219.53202.39
Operating Income
-25.1463.8959.3137.12-14.73-7
Net Income
-19.1948.5842.4246.59-36.78-16.42
Earnings Per Share
-0.130.320.280.36-0.33-0.15
EPS Growth
-13.14%-22.18%---

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
120.79166.12104.428265.9587.08
Total Debt
-22.5324.8451.5552.4753.29
Net Cash (Debt)
120.79143.5979.5730.4613.4833.79
Net Cash Growth
-2.48%80.45%161.28%125.96%-60.11%-23.17%
Net Cash Per Share
0.820.960.530.210.120.31

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
20.747466.226.78-17.89-1.98
Capital Expenditures
-1.62-1.03-1.68-1.99-1.51-3.22
Free Cash Flow
19.1272.9764.5124.79-19.41-5.2
Free Cash Flow Growth
-71.39%13.11%160.27%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
77.29%82.56%82.78%83.00%81.96%83.63%
Operating Margin
-8.28%15.26%17.00%11.54%-5.50%-2.89%
Pretax Margin
-7.37%15.83%16.42%9.53%-7.37%-4.98%
Profit Margin
-6.32%11.60%12.16%14.49%-13.73%-6.78%
FCF Margin
6.30%17.43%18.49%7.71%-7.25%-2.15%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-20.6433.3321.91--
Forward PE
-21.6132.8935.0812.6712.67
P/FCF Ratio
25.7213.7421.9141.17--
PS Ratio
1.622.404.053.171.182.77